Brewin Dolphin LTD Eli Lilly & CO Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Brewin Dolphin LTD holds 5,648 shares of LLY stock, worth $4.34 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,648

Previous 8,420 32.92%

Holding current value

$4.34 Million

Previous $2.41 Million 24.06%

% of portfolio

0.09%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	SELL	$278.73 - $327.27 $772,639 - $907,192	-2,772 Reduced 32.92%	5,648 $1.83 Million
Q1 2022 Nov 14, 2022	BUY	$234.69 - $291.66 $93,876 - $116,664	400 Added 4.99%	8,420 $2.41 Million
Q4 2021 Nov 14, 2022	BUY	$224.85 - $279.04 $1.8 Million - $2.24 Million	8,020 New	8,020 $2.22 Million
Q3 2021 Nov 09, 2023	BUY	$221.6 - $272.71 $12,852 - $15,817	58 Added 0.09%	62,241 $14.4 Billion
Q2 2021 Nov 09, 2023	BUY	$180.55 - $233.54 $24,374 - $31,527	135 Added 0.22%	62,183 $14.3 Billion
Q1 2021 Nov 09, 2023	SELL	$164.32 - $212.72 $9,859 - $12,763	-60 Reduced 0.1%	62,048 $11.6 Billion
Q3 2020 Nov 09, 2023	SELL	$146.22 - $169.13 $264,658 - $306,125	-1,810 Reduced 2.83%	62,108 $9.19 Billion
Q2 2020 Nov 09, 2023	SELL	$136.42 - $164.18 $62,071 - $74,701	-455 Reduced 0.71%	63,918 $10.5 Billion
Q1 2020 Nov 09, 2023	BUY	$119.05 - $147.35 $6.23 Million - $7.71 Million	52,321 Added 434.13%	64,373 $8.93 Billion
Q3 2019 Nov 09, 2023	SELL	$106.79 - $116.16 $23,493 - $25,555	-220 Reduced 1.79%	12,052 $1.35 Billion
Q2 2019 Nov 09, 2023	SELL	$110.79 - $129.32 $29,802 - $34,787	-269 Reduced 2.14%	12,272 $1.36 Billion
Q1 2019 Nov 09, 2023	SELL	$111.31 - $131.02 $71,461 - $84,114	-642 Reduced 4.87%	12,541 $1.63 Billion
Q4 2018 Nov 09, 2023	BUY	$105.9 - $118.64 $19,062 - $21,355	180 Added 1.38%	13,183 $1.53 Billion
Q3 2018 Nov 09, 2023	SELL	$85.86 - $107.31 $48,940 - $61,166	-570 Reduced 4.2%	13,003 $1.4 Billion
Q1 2018 Nov 09, 2023	BUY	$74.21 - $87.6 $22,485 - $26,542	303 Added 2.28%	13,573 $1.05 Billion
Q4 2017 Nov 09, 2023	SELL	$81.94 - $87.89 $13,602 - $14,589	-166 Reduced 1.24%	13,270 $1.12 Billion
Q3 2017 Nov 09, 2023	BUY	$77.07 - $85.54 $600,221 - $666,185	7,788	13,436 $1.15 Billion

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Eli Lilly & CO Transaction History